Literature DB >> 8276713

K-ras gene mutation in early ductal lesions induced in a rapid production model for pancreatic carcinomas in Syrian hamsters.

M Tsutsumi1, S Kondoh, O Noguchi, K Horiguchi, E Kobayashi, S Okita, K Ohashi, K Honoki, T Tsujiuchi, Y Konishi.   

Abstract

The presence of K-ras gene mutation was examined in experimentally induced preneoplastic pancreatic ductal lesions. Syrian hamsters received 70 mg/kg of N-nitrosobis(2-oxopropyl)amine (BOP) followed by repeated exposure to an augmentation pressure regimen consisting of choline-deficient diet combined with DL-ethionine and L-methionine and administration of 20 mg/kg BOP. After two augmentation pressure cycles, pancreatic ductal cell hyperplasias appeared and after three cycles, atypical hyperplasias of pancreatic ductal cells and intraductal carcinomas developed. K-ras mutations were detected by single-strand conformation polymorphism analysis of polymerase chain reaction products and nucleotide sequencing. The results showed that K-ras mutation had occurred in one of 9 simple hyperplasias of pancreatic ductal epithelium, in 5 of 9 atypical hyperplasias, and in 4 of 8 intraductal carcinomas. The findings thus suggested that K-ras is activated in association with very early stage malignant transformation of pancreatic ductal cells in hamsters.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8276713      PMCID: PMC5919083          DOI: 10.1111/j.1349-7006.1993.tb02807.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


N‐nitrosobis(2‐oxopropyl)amine choline‐deficient diet polymerase chain reaction single‐strand conformation polymorphism
  23 in total

1.  Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction.

Authors:  M Orita; Y Suzuki; T Sekiya; K Hayashi
Journal:  Genomics       Date:  1989-11       Impact factor: 5.736

2.  K-ras mutation is an early event in pancreatic duct carcinogenesis in the Syrian golden hamster.

Authors:  W L Cerny; K A Mangold; D G Scarpelli
Journal:  Cancer Res       Date:  1992-08-15       Impact factor: 12.701

3.  Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms.

Authors:  M Orita; H Iwahana; H Kanazawa; K Hayashi; T Sekiya
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

4.  Rapid production of pancreatic carcinoma by initiation with N-nitroso-bis(2-oxopropyl)amine and repeated augmentation pressure in hamsters.

Authors:  K Mizumoto; M Tsutsumi; A Denda; Y Konishi
Journal:  J Natl Cancer Inst       Date:  1988-12-07       Impact factor: 13.506

5.  Methylation of hamster DNA by the carcinogen N-nitroso-bis (2-oxopropyl)amine.

Authors:  T A Lawson; R Gingell; D Nagel; L A Hines; A Ross
Journal:  Cancer Lett       Date:  1981-01       Impact factor: 8.679

6.  Ras gene mutations in intraductal papillary neoplasms of the pancreas. Analysis in five cases.

Authors:  M Tada; M Omata; M Ohto
Journal:  Cancer       Date:  1991-02-01       Impact factor: 6.860

7.  High frequency of Ki-ras codon 12 mutations in pancreatic adenocarcinomas.

Authors:  K Grünewald; J Lyons; A Fröhlich; H Feichtinger; R A Weger; G Schwab; J W Janssen; C R Bartram
Journal:  Int J Cancer       Date:  1989-06-15       Impact factor: 7.396

8.  Frequency and types of point mutation at the 12th codon of the c-Ki-ras gene found in pancreatic cancers from Japanese patients.

Authors:  M Mariyama; K Kishi; K Nakamura; H Obata; S Nishimura
Journal:  Jpn J Cancer Res       Date:  1989-07

9.  Frequent glycine-to-aspartic acid mutations at codon 12 of c-Ki-ras gene in human pancreatic cancer in Japanese.

Authors:  Y Nagata; M Abe; K Motoshima; E Nakayama; H Shiku
Journal:  Jpn J Cancer Res       Date:  1990-02

10.  Comparison of K-ras oncogene activation in pancreatic duct carcinomas and cholangiocarcinomas induced in hamsters by N-nitrosobis(2-hydroxypropyl)amine.

Authors:  M Tsutsumi; Y Murakami; S Kondoh; T Tsujiuchi; K Hohnoki; K Horiguchi; O Noguchi; E Kobayashi; S Okita; T Sekiya
Journal:  Jpn J Cancer Res       Date:  1993-09
View more
  12 in total

Review 1.  Chemoprevention for pancreatic cancer.

Authors:  Robert A Wolff
Journal:  Int J Gastrointest Cancer       Date:  2003

2.  Mutagenic activation of N-nitrosobis(2-oxopropyl)amine by pancreatic juice and assessment of its ductal tumorigenicity following intraductal administration in dogs.

Authors:  T Kamano; Y Mori; K Suda; M Takahashi; T Uchida; T Takada; M Tsutsumi; Y Konishi
Journal:  Int J Pancreatol       Date:  1996-08

Review 3.  K-Ras mutations and benign pancreatic disease.

Authors:  M Löhr; P Maisonneuve; A B Lowenfels
Journal:  Int J Pancreatol       Date:  2000-04

Review 4.  Involvement of inflammatory factors in pancreatic carcinogenesis and preventive effects of anti-inflammatory agents.

Authors:  Mami Takahashi; Michihiro Mutoh; Rikako Ishigamori; Gen Fujii; Toshio Imai
Journal:  Semin Immunopathol       Date:  2012-09-07       Impact factor: 9.623

5.  Characterization of three cloned cell lines from a N-nitrosobis(2-hydroxypropyl)amine-induced transplantable hamster pancreatic ductal adenocarcinoma.

Authors:  T Mori; M Tsutsumi; O Noguchi; K Horiguchi; K Hohnoki; S Okita; F Suzuki; Y Konishi
Journal:  Int J Pancreatol       Date:  1994 Oct-Dec

6.  The role of tobacco-derived carcinogens in pancreas cancer.

Authors:  Rajiv Lochan; Helen L Reeves; Anne K Daly; Richard M Charnley
Journal:  ISRN Oncol       Date:  2011-07-17

7.  Infrequent mutation of lysophosphatidic Acid receptor-1 gene in hamster pancreatic duct adenocarcinomas and established cell lines.

Authors:  Toshifumi Tsujiuchi; Mami Furukawa; Yumi Obo; Ayako Yamasaki; Mayuko Hotta; Chie Kusunoki; Naoko Suyama; Toshio Mori; Kanya Honoki; Nobuyuki Fukushima
Journal:  J Toxicol Pathol       Date:  2009-04-06       Impact factor: 1.628

8.  Ki-ras point mutations and proliferation activity in biliary tract carcinomas.

Authors:  K Ohashi; M Tstsumi; Y Nakajima; H Nakano; Y Konishi
Journal:  Br J Cancer       Date:  1996-09       Impact factor: 7.640

9.  Characterization and use of HapT1-derived homologous tumors as a preclinical model to evaluate therapeutic efficacy of drugs against pancreatic tumor desmoplasia.

Authors:  Sujit Suklabaidya; Biswajit Das; Syed Azmal Ali; Sumeet Jain; Sharada Swaminathan; Ashok K Mohanty; Susen K Panda; Pujarini Dash; Subhankar Chakraborty; Surinder K Batra; Shantibhusan Senapati
Journal:  Oncotarget       Date:  2016-07-05

10.  K-ras and p53 alterations in genomic DNA and transcripts of human pancreatic adenocarcinoma cell lines.

Authors:  H Suwa; T Yoshimura; N Yamaguchi; K Kanehira; T Manabe; M Imamura; H Hiai; M Fukumoto
Journal:  Jpn J Cancer Res       Date:  1994-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.